CHROMADERM
Chromaderm develops a topical inhibitor of melanin production as a first-in-class therapy for skin brightening, melasma, and other skin diseases associated with increased melanin production.
Similar Organizations
Ion Biotechnology (USA), Inc.
Ion Biotechnology is developing drugs based on ionic metals which show promise against a range of cancers and infectious disease.
Sunol Molecular
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.
Tilden Bio
Tilden Bio develops photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins.